SYFOVRE (pegcetacoplan) injection, for intravitreal use
Initial U.S. Approval: 2021
Syfovre injection is used to treat geographic atrophy (GA), which is the dry, advanced form of age-related macular degeneration (AMD). Syfovre injection works to slow the growth of GA lesions and to help preserve vision by reducing more significant vision loss and blindness.
| Brand Name: | SYFOVRE |
| Generic Name: | pegcetacoplan |
| Strength: | Injection: 150 mg/mL in a single-dose vial. |
| Manufacturer: | Apellis Pharmaceuticals, Inc. |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “SYFOVRE (pegcetacoplan) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for SYFOVRE (pegcetacoplan) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
